NXGL
NEXGEL, Inc.
1W: -16.1%
1M: -42.8%
3M: -57.0%
YTD: -62.7%
1Y: -78.2%
3Y: -58.6%
$0.70
+0.03 (+3.72%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$7.2M
52W Range0.65-3.25
Volume124,103
Avg Volume263,408
Beta0.62
Dividend—
Analyst Ratings
Company Info
CEOAdam R. Levy
Employees19
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2021-12-22
Websitenexgel.com
2150 Cabot Boulevard West
Langhorne, PA 19047
US
Langhorne, PA 19047
US
215 702 8550
About NEXGEL, Inc.
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
Latest News
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
EXCLUSIVE: NexGel To Acquire Regenerative Biomaterial Portfolio From Celularity, Expects To Triple Revenue
NEXGEL Announces Financing of $1.797 Million Relating to an Acquisition Targeted to Close in the First Quarter of 2026, Subject to the Completion of Due Diligence
NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Levy Adam R. | S-Sale | 4,000 | $2.52 | 2025-11-06 |
| Henry Scott Robert | S-Sale | 7,175 | $2.55 | 2025-10-03 |
| Levy Adam R. | S-Sale | 2,400 | $2.55 | 2025-10-03 |
| Henry Scott Robert | S-Sale | 825 | $2.50 | 2025-10-02 |
| Levy Adam R. | S-Sale | 1,600 | $2.50 | 2025-10-02 |